glp-1 drug exposure pharmaceutical companies 2025 Receptor Agonist Market Size and Share Top 12 Pharma: Pfizer Tops

doi: 10.2337/dc20-1843, PMID: [DOI] [PubMed] [Google Scholar] 88

Risk of stability and dosing accuracy GLP-1 receptor agonist medications are typically available in pre-filled injection form to deliver a precise dose

[Source: Fierce Pharma ] February 2025 Eli Lilly committed another $5.3 billion toward a manufacturing hub in Indiana to meet explosive demand for Mounjaro and Zepbound

However, regulatory uncertainties (pharma import tariffs, FDA scrutiny) mean many established biologics are still made in the US/EU companies favored sites ( [49] )

Contribution statement CX was involved in the conception and design of the study, data collection and interpretation, statistical analysis and writing the manuscript